Close X
Attorney Spotlight

How did Mike DeAgro's experience co-founding a nonprofit advocacy organization lead to a career in the legal field? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Attorney Spotlight: Robert Platt

June 5, 2018
Robert Platt spotlight

1. Tell us about your practice.

My practice over the last four years has largely focused on: (1) representing companies and individuals that are the subject of government investigations and (2) conducting internal investigations for corporations concerned about possible misconduct, principally in the life science and healthcare sectors. Earlier this year, I gained significant trial experience representing a former executive who was charged with, among other things, conspiracy to commit mail and wire fraud. After a multi-month trial, a jury acquitted our client on six of seven charges, including participating in a conspiracy and making material false statements. Moreover, I have also successfully aided several government contractors responding to administrative actions such as suspension and debarment for alleged contractual or ethical violations. 

2. What is an interesting trend happening right now related to your field of practice?

The government and whistleblowers continue to aggressively pursue enforcement actions to protect the public from healthcare fraud waste and abuse. Along those lines, whistleblowers are retaining increasingly sophisticated counsel who are more willing to proceed even when the government declines to intervene. 

3. Why did you choose to pursue a career in the legal field? 

Prior to law school, I had ambitions of a career in healthcare policy. While in undergrad at The George Washington University, I spent a couple years working in the government affairs department of a pharmaceutical company and grew passionate about major policy battles occurring on the Hill at the time, including healthcare reform. As college came to an end, I believed that in order to be an effective policy advocate, I needed to have a strong grasp of the laws I would seek to influence. Law school and a Masters of Public Health seemed liked the next logical step. However, what I did not account for was that I would become drawn to the practice of law and how such a complex system, with such a wide variety of participants, could so effectively bring resolution to difficult issues. After a few semesters, I decided to put policy in the rearview.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.